You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hepatic carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatic Carcinoma, Hepatic Metastasis Trial in Pamplona (Octreotide, Placebo)

Recruiting
  • Hepatic Carcinoma
  • Hepatic Metastasis
  • Pamplona, Spain
    Clinica Universidad de Navarra
Oct 10, 2023

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Adebrelimab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Jul 27, 2023

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Frankfurt, Hannover, Jena (Delcath Hepatic Delivery System,

Terminated
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • Frankfurt, Germany
  • +2 more
Oct 13, 2022

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Hepatic Carcinoma Trial in Guangzhou (NanoKnife LEDC System)

Completed
  • Hepatic Carcinoma
  • NanoKnife LEDC System
  • Guangzhou, Guangdong, China
    FUDA Cancer Hospital
Sep 1, 2021

Magnetic Resonance Imaging in Evaluation of Patient Affected by

Recruiting
  • Colorectal Cancer
  • Hepatic MRI
  • Roma, Italy
    Policlinico Agostino Gemelli
Jul 10, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 24, 2023

Thrombocytopenia, Hepatocellular Carcinoma Trial in Guangzhou (Avatrombopag)

Not yet recruiting
  • Thrombocytopenia
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 17, 2023

Hepatic Carcinoma Trial in Guangzhou (NanoKnife)

Completed
  • Hepatic Carcinoma
  • NanoKnife
  • Guangzhou, Guangdong, China
    中国
Sep 1, 2021

Radiotherapy With Iron Oxide Nanoparticles on MR-Linac for

Recruiting
  • Liver Neoplasms
  • +8 more
  • Ferumoxytol injection
  • Pittsburgh, Pennsylvania
    Allegheny General Hospital
Dec 14, 2021

HVPG and ICG-R15 in Short- and Medium-term Results of Surgery of

Recruiting
  • Hepatocellular Carcinoma
  • Hepatic venous-portal gradient (HVPG) measurement
  • Napoli, Italy
    Federico II University Hospital
Mar 24, 2023

circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC

Not yet recruiting
  • Hepatic Cell Carcinoma
    • (no location specified)
    Sep 12, 2023

    Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Zoledronic acid)

    Recruiting
    • Hepatocellular Carcinoma
    • HAIC
    • Zoledronic acid
    • Guangzhou, Guangdong, China
      Cancer Center Sun Yat-sen University
    May 10, 2023

    Metastatic Pancreatic Carcinoma Trial in Providence (CAR2 Anti-CEA CAR-T cells)

    Terminated
    • Metastatic Pancreatic Carcinoma
    • CAR2 Anti-CEA CAR-T cells
    • Providence, Rhode Island
      Roger Williams Medical Center
    Jan 12, 2023

    Hepatocellular Carcinoma Trial in Guangzhou (TACE-HACI, plus atezolizumab-bevacizumab)

    Recruiting
    • Hepatocellular Carcinoma
    • TACE-HACI, plus atezolizumab-bevacizumab
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Feb 20, 2023

    A Study to Evaluate Vaccines Against COVID-19 in the Real World

    Withdrawn
    • Chronic Liver Disease
    • Hepatic Carcinoma
      • Hong Kong, Hong Kong
        Humanity & Health Medical Group
      Aug 1, 2022

      Hepatocellular Carcinoma Trial (HAIC(FOLFOX), Oxaliplatin, Leucovorin)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • HAIC(FOLFOX)
      • +5 more
      • (no location specified)
      Aug 16, 2022

      Macrotrabecular Massive Hepatocellular Carcinoma Trial in Wuhan (HAIC, Camrelizumab plus Apatinib)

      Recruiting
      • Macrotrabecular Massive Hepatocellular Carcinoma
      • HAIC
      • Camrelizumab plus Apatinib
      • Wuhan, Hubei, China
        Hepatic Surgery Center, Tongji Hospital, Tongji Medical College,
      May 1, 2023

      Liver Carcinoma, Hepatic Cell Carcinoma Trial in Wuhan (CAR-GPC3 T cells)

      Recruiting
      • Liver Carcinoma
      • Hepatic Cell Carcinoma
      • CAR-GPC3 T cells
      • Wuhan, Hubei, China
        Tao Zhang
      Nov 20, 2023

      Potentially Resectable Hepatocellular Carcinoma Trial (FOLFOX-HAIC+Lenvatinib+Envolizumab)

      Not yet recruiting
      • Potentially Resectable Hepatocellular Carcinoma
      • (no location specified)
      Nov 16, 2023

      Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • Portal Hypertension
      • TACE ± Systemic therapy
      • Nanjing, China
      • +1 more
      Jan 28, 2023

      Hepatocellular Carcinoma Trial in Wuhan (Nocardia rubra cell wall skeleton, Hepatic arterial infusion chemo, Lenvatinib)

      Recruiting
      • Hepatocellular Carcinoma
      • Nocardia rubra cell wall skeleton
      • +3 more
      • Wuhan, Hubei, China
        Hepatic Surgery Center, Tongji Hospital, Tongji Medical College,
      Sep 5, 2022

      Hepatocellular Carcinoma Trial (Donafenib, TACE)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • (no location specified)
      Oct 8, 2022

      Unrescetable Hepatocellular Carcinoma Trial in Tianjin (HAIC+Durvalumab+Tremelimumab+Bevacizumab)

      Not yet recruiting
      • Unrescetable Hepatocellular Carcinoma
      • Tianjin, Tianjin, China
        Tianjin Cancer Hospital Airport Hospital
      May 16, 2023